MONASH University-led research has shown that blood tests measuring brain-specific proteins can track neurobiological recovery after sport-related concussions, aiding safer return-to-play decisions. By analysing 137 athletes, researchers found biomarkers like GFAP and NfL remain elevated for weeks in severe cases, particularly those involving loss of consciousness. This study highlights the need for biomarker-based return-to-play guidelines alongside symptom assessment. While more work is needed for clinical adoption, the findings emphasize cautious recovery timelines, especially in community sports.
22December2024